Medical Oncology & Hematology
The partnership between Dana-Farber and St. Elizabeth’s allows patients to receive the benefit of Dana-Farber’s advances in technology and research with the comfort and convenience of being at their local hospital.
The Dana-Farber Cancer Institute delivers the latest medical oncology care, including chemotherapy, biologic, and targeted therapy, as well as treatment for benign hematologic disorders. Patients also have local access to select Dana-Farber clinical trials that explore new cancer therapies.
Dana-Farber closely coordinates with surgical and radiation oncologists at St. Elizabeth’s Medical Center to develop the best possible treatment plan for each patient. Expert imaging, radiation oncology, and surgical services at St. Elizabeth’s enable patients to receive comprehensive care in one convenient location. A full range of clinical and support services is available to help patients and their families through treatment, including:
- Genetic counseling
- Social work
- Spiritual care
- Support groups
Dana-Farber Cancer Institute at St. Elizabeth's Medical Center is pleased to welcome Chris Lathan, MD, MS, MPH, as medical director. Dr. Lathan is a medical oncologist and an assistant professor of medicine at Harvard Medical School. He holds a master's degree in public health from the Harvard School of Public Health, and a Master of Science in cellular and molecular biology from the University of Massachusetts.
Olga Kozyreva, MD
Associate Medical Director/Genitourinary and General Medical Oncology
Christopher Lathan, MD, MS, MPH
Julia Hayes, MD
Caroline C. Block, MD
Darren M. Evanchuk, MD
Jeffrey S. Wisch, MD
Pablo Leone, MD